combination therapy with glp-1 receptor agonist and sglt2 inhibitor cardiometabolic in type 2 diabetes: optimizing GLP‑1 use | Current Atherosclerosis Reports GLP-1 Therapeutics and Their Brain & Sleep Type:Paperback

combination therapy with glp-1 receptor agonist and sglt2 inhibitor

combination therapy with glp-1 receptor agonist and sglt2 inhibitor cardiometabolic in type 2 diabetes: optimizing GLP‑1 use | Current Atherosclerosis Reports GLP-1 Therapeutics and Their Brain & Sleep Type:Paperback

Name: combination therapy with glp-1 receptor agonist and sglt2 inhibitor cardiometabolic in type 2 diabetes: optimizing GLP‑1 use | Current Atherosclerosis Reports GLP-1 Therapeutics and Their Brain & Sleep Type:Paperback
Brand: eveningdream.pl
SKU: 46735831870
Price: 27.21 USD
Availability: InStock
Rating: 4.4977 (7 reviews)

SKU: 46735831870

4.5

USD27.21 USD48.21

Pay in 4 interest-free payments of $6.80 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 3 - Sep 8

Description

combination therapy with glp-1 receptor agonist and sglt2 inhibitor cardiometabolic in type 2 diabetes: optimizing GLP‑1 use | Current Atherosclerosis Reports GLP-1 Therapeutics and Their Brain & Sleep Type:Paperback

GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer - PMC

doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

Brain & Sleep

Type:Paperback

As a GLP-1 receptor agonist, it mimics the body's own hormone GLP-1 (glucagon-like peptide-1) and selectively binds to the GLP-1 receptor, thereby stimulating the secretion of insulin and lowering blood glucose levels [15]

Exchange/Return Notes